Sigyn Therapeutics (OTCMKTS:SIGY) Releases Earnings Results

Sigyn Therapeutics (OTCMKTS:SIGY) posted its quarterly earnings results on Tuesday. The company reported ($2.51) earnings per share (EPS) for the quarter, Zacks reports.

Sigyn Therapeutics Price Performance

Shares of OTCMKTS:SIGY opened at $4.15 on Thursday. The company’s 50-day moving average price is $4.04 and its two-hundred day moving average price is $4.34. Sigyn Therapeutics has a 12 month low of $3.15 and a 12 month high of $6.34.

Sigyn Therapeutics Company Profile

Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.